U.S. Food and Drug Administration (FDA) Accepts for Priority Review Taiho Oncology’s New Drug Application for Futibatinib for Cholangiocarcinoma March 30, 2022
CHOP and Penn Medicine to Lead Philadelphia Regional Center for Children’s Environmental Health March 22, 2022